These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 7796592)

  • 1. The effect of small doses of progesterone released from two types of vaginal rings on ovarian activity and bleeding patterns during the first postpartum year.
    Landgren BM; Jonsson B; Cekan SZ
    Contraception; 1995 Apr; 51(4):255-60. PubMed ID: 7796592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
    Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
    Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
    Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
    Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteinizing hormone releasing hormone agonist for contraception in breast feeding women.
    Fraser HM; Dewart PJ; Smith SK; Cowen GM; Sandow J; McNeilly AS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):996-1002. PubMed ID: 2507572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contraception with progestogens and progesterone during lactation.
    Shaaban MM
    J Steroid Biochem Mol Biol; 1991; 40(4-6):705-10. PubMed ID: 1835650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsatile GnRH stimulates normal cyclic ovarian function in amenorrheic lactating postpartum women.
    Zinaman MJ; Cartledge T; Tomai T; Tippett P; Merriam GR
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2088-93. PubMed ID: 7608260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone-releasing vaginal rings for use in postpartum contraception. II. Pharmacokinetic profiles in women.
    Landgren BM; Hall PE; Cekan SZ
    Contraception; 1992 Apr; 45(4):343-9. PubMed ID: 1516366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
    Stanczyk FZ; Miyakawa I; Goebelsmann U
    Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and determinants of postpartum ovarian function in women in the United States.
    Campbell OM; Gray RH
    Am J Obstet Gynecol; 1993 Jul; 169(1):55-60. PubMed ID: 8333476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast-feeding and return to fertility: clinical evidence from Pakistan, Philippines and Thailand.
    Kennedy KI
    Asia Pac Popul J; 1990 Mar; 5(1):45-56. PubMed ID: 12283348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
    Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D
    Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
    Alvarez-Sanchez F; Brache V; Jackanicz T; Faundes A
    Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraceptive effects of extended lactational amenorrhoea: beyond the Bellagio Consensus.
    Short RV; Lewis PR; Renfree MB; Shaw G
    Lancet; 1991 Mar; 337(8743):715-7. PubMed ID: 1672186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New IPPF statement on breastfeeding, fertility and post-partum contraception.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary, ovarian and endometrial effects of progesterone released prematurely during the proliferative phase.
    Shumin X; Johannisson E; Landgren BM; Diczfalusy E
    Contraception; 1983 Feb; 27(2):177-93. PubMed ID: 6851555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.